tiprankstipranks
Trending News
More News >
INNOVATE Corp (VATE)
NYSE:VATE
US Market
Advertisement

INNOVATE Corp (VATE) Earnings Dates, Call Summary & Reports

Compare
266 Followers

Earnings Data

Report Date
Oct 30, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
Last Year’s EPS
-1.18
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed performance for INNOVATE. While significant strides were made in increasing backlog and achieving growth in the Life Sciences segment and R2, the company faced notable challenges with a substantial decrease in consolidated revenue and a net loss for the quarter. The successful debt refinancing is a positive development, but the overall financial performance indicates ongoing challenges.
Company Guidance
During the second quarter of 2025, INNOVATE Corp. reported consolidated revenues of $242 million, a decrease of 22.7% from the previous year, and an adjusted EBITDA of $15.7 million, down from $26.7 million. The Infrastructure segment saw a revenue decline of 23.6% to $233.1 million, with adjusted EBITDA reducing to $19.3 million, influenced by project timings and reduced margins. Life Sciences, however, showed an 88.2% increase in revenue to $3.2 million, driven by R2's sales, while Spectrum's revenue decreased by $500,000 to $5.7 million. Despite a net loss of $22 million, INNOVATE showed strategic progress, including a refinancing initiative to extend debt maturities, a robust backlog increase to over $1.3 billion, and ongoing pipeline optimism across segments.
Increase in DBM Global Backlog
DBM Global's adjusted backlog increased year-over-year by approximately $300 million to just over $1.3 billion, with an additional $400 million project expected to be added in the third quarter.
R2 Growth and Expansion
R2 reported strong growth with revenues increasing to $3.2 million from $1.7 million year-over-year. Notable achievements include a 115.1% increase in patient treatments, a 28.5% increase in average monthly utilization per provider, and significant growth in social media engagements, mentions, and web users.
Life Sciences Revenue Increase
The Life Sciences segment saw an 88.2% increase in revenue to $3.2 million, primarily driven by R2's growth in Glacial Spa unit sales, consumable sales, and international expansion.
Successful Debt Refinancing
INNOVATE successfully announced the early settlement of refinancing transactions, allowing for the extension of debt maturities and continuing pursuit of strategic plans.

INNOVATE Corp (VATE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VATE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 30, 2025
2025 (Q3)
- / -
-1.18
Aug 05, 2025
2025 (Q2)
- / -1.67
0.977-271.24% (-2.65)
May 06, 2025
2025 (Q1)
- / -1.89
-2.24915.96% (+0.36)
Mar 31, 2025
2024 (Q4)
- / -1.89
-2.24915.92% (+0.36)
Nov 06, 2024
2024 (Q3)
- / -1.18
-0.924-27.71% (-0.26)
Aug 07, 2024
2024 (Q2)
- / 0.98
-1.338173.02% (+2.31)
May 07, 2024
2024 (Q1)
- / -2.25
-1.303-72.60% (-0.95)
Mar 04, 2024
2023 (Q4)
- / -1.21
-0.896-35.49% (-0.32)
Nov 09, 2023
2023 (Q3)
- / -0.92
-0.844-9.48% (-0.08)
Aug 09, 2023
2023 (Q2)
- / -1.34
-1.74223.19% (+0.40)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

VATE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$5.76$5.68-1.39%
May 06, 2025
$6.24$6.15-1.44%
Mar 31, 2025
$7.83$7.31-6.64%
Nov 06, 2024
$5.14$5.16+0.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does INNOVATE Corp (VATE) report earnings?
INNOVATE Corp (VATE) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
    What is INNOVATE Corp (VATE) earnings time?
    INNOVATE Corp (VATE) earnings time is at Oct 30, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VATE EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis